Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.
Dohlman TH, Singh RB, Amparo F, Carreno-Galeano T, Dastjerdi M, Coco G, Di Zazzo A, Shikari H, Saboo U, Sippel K, Ciralsky J, Yoo SH, Sticca M, Wakamatsu TH, Murthy S, Hamrah P, Jurkunas U, Ciolino JB, Saeed H, Gomes JAP, Perez VL, Yin J, Dana R.
Dohlman TH, et al. Among authors: di zazzo a.
Ophthalmol Sci. 2024 Feb 13;4(4):100492. doi: 10.1016/j.xops.2024.100492. eCollection 2024 Jul-Aug.
Ophthalmol Sci. 2024.
PMID: 38682029
Free PMC article.